National Peroxide Share Price
599.00-2.50 (-2.79%)
-3.26% past 1 Year
Corporate filings & documents
Announcements
Please find enclosed herewith Newspaper Publication regarding Annual General Meeting of the Company.
2 weeks agoPlease find enclosed herewith Newspaper Publication regarding Annual General Meeting of the Company.
2 weeks agoPlease find enclosed herewith communication sent to shareholders regarding TDS on Dividend for FY 2025-26.
2 weeks agoPlease find enclosed herewith communication sent to shareholders regarding TDS on Dividend for FY 2025-26.
2 weeks agoPlease find attached herewith communication sent to the Shareholders pertaining to Notice of 6th Annual General Meeting along with Annual Report for FY 25-26
2 weeks agoPlease find attached herewith communication sent to the Shareholders pertaining to Notice of 6th Annual General Meeting along with Annual Report for FY 25-26
2 weeks agoPlease find attached herewith Notice of 6th Annual General Meeting of the Company along with Annual Report for FY 2025-26.
2 weeks agoPlease find attached herewith Notice of 6th Annual General Meeting of the Company along with Annual Report for FY 2025-26.
2 weeks agoPlease find attached herewith Annual Report of the Company for FY 2025-26 along with Notice of 6th Annual General meeting.
2 weeks agoPlease find attached herewith Annual Report of the Company for FY 2025-26 along with Notice of 6th Annual General meeting.
2 weeks agoPlease find attached herewith Annual Report of the Company for FY 2025-26 along with Notice of Annual General meeting.
2 weeks agoPlease find enclosed herewith Newspaper Publication regarding Annual General meeting of the Company.
2 weeks agoPlease find enclosed herewith Newspaper Publication regarding Annual General meeting of the Company.
2 weeks agoPlease find attached Copies of Newpaper Publication of the Extract of the Revised Audited Financial Results for the Quarter & year ended March 31 2026 and Unaudited Financial results for the Quarter ended June 30 2026.
1 month agoPlease find attached Copies of Newpaper Publication of the Extract of the Revised Audited Financial Results for the Quarter & year ended March 31 2026 and Unaudited Financial results for the Quarter ended June 30 2026.
1 month agoThe Board of Directors at its meeting held on April 30 2026 had recommend the final dividend 70% being Rs. 7 per equity share of Rs. 10 each for the financial year ended March 31 2026. The recommendation remains unchanged and is subject to approval of the members at the ensuing Annual General meeting.
1 month agoThe Board of Directors at its meeting held on April 30 2026 had recommend the final dividend 70% being Rs. 7 per equity share of Rs. 10 each for the financial year ended March 31 2026. The recommendation remains unchanged and is subject to approval of the members at the ensuing Annual General meeting.
1 month agoPlease find details of Book Closure of dates for Annual General meeting.
1 month agoPlease find details of Book Closure of dates for Annual General meeting.
1 month agoPlease find attached herewith details of Annual general Meeting of the Company.
1 month agoPlease find attached herewith details of Annual general Meeting of the Company.
1 month agoThe Board has in its meeting held August 12 2026 has recommended the reappointment of the Statutory Auditor of the Company.
1 month agoThe Board has in its meeting held August 12 2026 has recommended the reappointment of the Statutory Auditor of the Company.
1 month agoPlease find attached herewith unaudited financial results for quarter ended June 30 2026
1 month agoPlease find attached herewith unaudited financial results for quarter ended June 30 2026
1 month agoPlease find attached herewith Revised Financial results for the quarter and year ended March 31 2026
1 month agoPlease find attached herewith Revised Financial results for the quarter and year ended March 31 2026
1 month agoThis is to inform you that the Board of Directors of the Company at their meeting held today i.e. on Wednesday August 12 2026 have inter-alia considered and approved the following: 1. Statement of Revised Audited Financial Results & Revised Audit Report for the quarter and financial year ended March 31 2026 ; 2. Unaudited Financial Results for the quarter ended June 30 2026 and other matters
1 month agoThis is to inform you that the Board of Directors of the Company at their meeting held today i.e. on Wednesday August 12 2026 have inter-alia considered and approved the following: 1. Statement of Revised Audited Financial Results & Revised Audit Report for the quarter and financial year ended March 31 2026 ; 2. Unaudited Financial Results for the quarter ended June 30 2026 and other matters
1 month agoThis is to inform you that the Board of Directors of the Company at their meeting held today i.e. on Wednesday August 12 2026 have inter-alia considered and approved the following: 1. Statement of Revised Audited Financial Results & Revised Audit Report for the quarter and financial year ended March 31 2026 ; 2. Unaudited Financial Results for the quarter ended June 30 2026 and other matters
1 month agoThis is to inform you that the Board of Directors of the Company at their meeting held today i.e. on Wednesday August 12 2026 have inter-alia considered and approved the following: 1. Statement of Revised Audited Financial Results & Revised Audit Report for the quarter and financial year ended March 31 2026 ; 2. Unaudited Financial Results for the quarter ended June 30 2026 and other matters
1 month agoNational Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve i. Revised Audited Financial Results of the Company for the quarter and financial year ended March 31 2026 and Revised Audited Financial Statements for the financial year ended March 31 2026 ii. Un-audited Financial Results of the Company for the quarter ended June 30 2026;
1 month agoNational Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve i. Revised Audited Financial Results of the Company for the quarter and financial year ended March 31 2026 and Revised Audited Financial Statements for the financial year ended March 31 2026 ii. Un-audited Financial Results of the Company for the quarter ended June 30 2026;
1 month agoThe Board Meeting to be held on 03/08/2026 Stands Cancelled.
1 month agoThe Board Meeting to be held on 03/08/2026 Stands Cancelled.
1 month agoNational Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 inter alia to consider and approve Unaudited Financial Results for quarter ended 30th June 2026.
1 month agoNational Peroxide Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2026 inter alia to consider and approve Unaudited Financial Results for quarter ended 30th June 2026.
1 month agoPlease find attached resignation of Chief Information Officer of the Company.
2 months agoPlease find attached resignation of Chief Information Officer of the Company.
2 months agoCertificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026 is enclosed herewith.
2 months agoCertificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended June 30 2026 is enclosed herewith.
2 months agoThe Company has informed the Stock Exchange about the closure of Trading window.
2 months agoThe Company has informed the Stock Exchange about the closure of Trading window.
2 months agoPlease find attached Annual Secretarial Compliance Report of the Company for financial year ended March 31 2026
4 months agoPlease find attached clipping of Newspaper Publication.
4 months agoPlease find attached Financial Results.
4 months agoPlease find attached Financial Results.
4 months agoThe Company hereby informs that The Board of Directors in its meeting held on April 30 2026 has approved the appointment of Chief Financial Officer of the Company
4 months agoThe Company hereby informs that The Board of Directors in its meeting held on April 30 2026 has approved the appointment of Chief Financial Officer of the Company
4 months agoThe Company hereby informs the Exchange that Mr. Amit Goriwale has step down from the position of Interim Chief Financial Officer of the Company from close of business hours May 31 2026
4 months agoAnnual reports
Concalls & investor presentations
No presentations found